Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioreactor Design and Operational System01:29

Bioreactor Design and Operational System

Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
Bioplastics01:27

Bioplastics

Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...
Production of Biopesticides01:18

Production of Biopesticides

Biopesticides offer a sustainable alternative to chemical pesticides, utilizing microbial agents to control agricultural pests. Bacillus thuringiensis (Bt) is a widely employed bacterium known for its potent insecticidal activity. Bt biopesticides are favored for their specificity to insect pests, minimal environmental impact, and natural degradability.Mechanism of Bt Toxin Action Bt produces insecticidal crystal (Cry) proteins during its sporulation phase. These proteins form parasporal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA methylation signatures distinguish extranodal NK/T-cell lymphoma and EBV-positive nodal T/NK-cell lymphoma and identify prognostic subgroups.

Leukemia·2026
Same author

Efficacy and Safety of Modified Sishen Decoction for Tyrosine Kinase Inhibitor-Induced Diarrhea in Hepatocellular Carcinoma: A Randomized Controlled Trial.

Journal of hepatocellular carcinoma·2026
Same author

The Plant RABC1 GTPase Coordinates with Exocyst Component SEC5A in Regulating ER-phagy under Endoplasmic Reticulum Stress.

The Plant cell·2026
Same author

Comparative effectiveness of radical surgery versus concurrent chemoradiotherapy in stages IB3, IIA2, or locally resectable IIICr cervical cancer: a prospective, multicenter, propensity score-matched cohort study.

BMC cancer·2026
Same author

Affiliate Stigma Among Caregivers of Older People Living with HIV: A Descriptive Phenomenological Study.

Behavioral sciences (Basel, Switzerland)·2026
Same author

Growth differentiation factor-15 and the incidence, bidirectional progression, and risk prediction of atherosclerotic cardiovascular disease and metabolic dysfunction-associated steatotic liver disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3.

Cardiovascular diabetology·2026

Related Experiment Video

Updated: Jun 3, 2026

Operation of a Benchtop Bioreactor
12:54

Operation of a Benchtop Bioreactor

Published on: September 12, 2013

Plant bioreactors for pharmaceuticals.

Yansong Miao1, Yu Ding, Qiao-Yang Sun

  • 1Department of Biology and Molecular Biotechnology Program, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China.

Biotechnology & Genetic Engineering Reviews
|March 18, 2011
PubMed
Summary

Plant bioreactors offer economic pharmaceutical production. This review covers progress in plant expression systems, focusing on protein targeting and strategies for improved bioreactor development.

More Related Videos

Cultivation of Mammalian Cells Using a Single-use Pneumatic Bioreactor System
11:42

Cultivation of Mammalian Cells Using a Single-use Pneumatic Bioreactor System

Published on: October 10, 2014

Microalgae Cultivation and Biomass Quantification in a Bench-Scale Photobioreactor with Corrosive Flue Gases
08:41

Microalgae Cultivation and Biomass Quantification in a Bench-Scale Photobioreactor with Corrosive Flue Gases

Published on: December 19, 2019

Related Experiment Videos

Last Updated: Jun 3, 2026

Operation of a Benchtop Bioreactor
12:54

Operation of a Benchtop Bioreactor

Published on: September 12, 2013

Cultivation of Mammalian Cells Using a Single-use Pneumatic Bioreactor System
11:42

Cultivation of Mammalian Cells Using a Single-use Pneumatic Bioreactor System

Published on: October 10, 2014

Microalgae Cultivation and Biomass Quantification in a Bench-Scale Photobioreactor with Corrosive Flue Gases
08:41

Microalgae Cultivation and Biomass Quantification in a Bench-Scale Photobioreactor with Corrosive Flue Gases

Published on: December 19, 2019

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Pharmaceutical Production

Background:

  • Plant bioreactors are cost-effective systems for producing pharmaceuticals.
  • Several plant expression platforms exist, showing varied success.
  • Further advancements are crucial for optimizing plant bioreactor efficiency.

Purpose of the Study:

  • To review recent advancements in plant bioreactor expression systems.
  • To discuss strategies for enhancing plant bioreactor efficacy.
  • To explore protein compartmentation within plant organelles for improved production.

Main Methods:

  • Literature review of plant bioreactor technologies.
  • Analysis of protein targeting and localization strategies.
  • Discussion of methods for improving plant expression systems.

Main Results:

  • Overview of current plant bioreactor capabilities and limitations.
  • Identification of key areas for future development in plant-based pharmaceutical manufacturing.
  • Exploration of organelle-specific protein accumulation techniques.

Conclusions:

  • Plant bioreactors show significant promise for pharmaceutical synthesis.
  • Targeted protein delivery to specific organelles can enhance yields.
  • Continued innovation is necessary to fully realize the potential of plant bioreactors.